September 2010





This page gives you a listing of everything that has happened on the site this month. There are no active links.


    08.00.34e, Infliximab (Remicade®)
    Notification
    Posted: 9/30/2010


    08.00.33h, Trastuzumab (Herceptin®)
    Notification
    Posted: 9/30/2010


    08.00.86, Ecallantide (Kalbitor®)
    Notification
    Posted: 9/30/2010


    08.00.85, Tocilizumab (Actemra®)
    Notification
    Posted: 9/30/2010


    08.00.26l, Botulinum Toxin Agents
    Notification
    Posted: 9/30/2010


    08.00.84, Eculizumab (Soliris®)
    Notification
    Posted: 9/30/2010


    08.00.76b, Oxaliplatin (Eloxatin®)
    Notification
    Posted: 9/30/2010


    08.00.25f, Epoprostenol (Flolan®) and Treprostinil (Remodulin®)
    Notification
    Posted: 9/30/2010


    08.00.67e, Cetuximab (Erbitux®)
    Notification
    Posted: 9/30/2010


    08.00.66f, Bevacizumab (Avastin®)
    Notification
    Posted: 9/30/2010


    08.00.51c, Enzyme Replacement for the Treatment of Gaucher's Disease (eg, Alglucerase [Ceredase®], Imiglucerase [Cerezyme®], Velaglucerase Alpha [VPRIV™]).
    Notification
    Posted: 9/30/2010


    08.00.50h, Rituximab (Rituxan®)
    Notification
    Posted: 9/30/2010


    08.00.13h, Immune Globulin: Intravenous (IVIG), Subcutaneous (SCIG)
    Notification
    Posted: 9/30/2010


    11.06.07, Ovarian and Internal Iliac Vein Embolization as Treatment for Pelvic Congestion Syndrome
    Reissue
    Posted: 9/30/2010


    08.00.82a, Ustekinumab (Stelara™) for Subcutaneous Injection
    Notification
    Posted: 9/29/2010


    08.00.74b, Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists (eg, ranibizumab [Lucentis®], pegaptanib sodium [Macugen®])
    Policy Update
    Posted: 9/29/2010


    06.02.17b, Serodiagnosis of Inflammatory Bowel Disease (IBD)
    Reissue
    Posted: 9/24/2010


    11.03.11f, Procedures for the Treatment of Gastroesophageal Reflux Disease (GERD)
    Reissue
    Posted: 9/24/2010


    11.03.11f, Procedures for the Treatment of Gastroesophageal Reflux Disease (GERD)
    Reissue
    Posted: 9/24/2010


    06.02.31, Genetic Testing for Congenital Long QT Syndrome
    Reissue
    Posted: 9/24/2010


    Coverage of Influenza Vaccine for 2010-2011
    News Article
    Posted: 9/22/2010


    11.02.01g, Treatment of Varicose Veins of the Lower Extremities and Perforator Vein Incompetence
    Policy Update
    Posted: 9/22/2010


    08.00.94, Denosumab (Prolia™)
    Notification
    Posted: 9/16/2010


    08.00.77a, Human Papillomavirus (HPV) Vaccine(s)
    Policy Update
    Posted: 9/15/2010


    02.01.02, Private Duty Nursing
    Notification
    Posted: 9/15/2010


    11.14.19e, Artificial Intervertebral Disc Insertion
    Notification
    Posted: 9/15/2010


    07.07.03f, Photodynamic Therapy (PDT) Using Levulan® Kerastick® (Aminolevulinic Acid HCl [ALA]) or Metvixia® (Methyl Aminolevulinate)
    Notification
    Posted: 9/15/2010


    05.00.55e, Wheelchair Cushions and Seating
    Notification
    Posted: 9/15/2010


    00.01.44b, Never Events and Preventable Adverse Events
    Notification
    Posted: 9/15/2010


    08.00.55c, Omalizumab (Xolair®)
    Notification
    Posted: 9/13/2010


    11.08.04f, Selective Photothermolysis Using Pulsed-Dye Lasers (PDL)
    Policy Update
    Posted: 9/8/2010


    10.00.01b, Hippotherapy/Equestrian Therapy
    Policy Archived
    Posted: 9/03/2010


    00.01.14h, Reporting and Documentation Requirements for Anesthesia Services
    Policy Update
    Posted: 9/1/2010


    08.09.11i, Medicare Part B vs. Part D Crossover Drugs
    Policy Update
    Posted: 9/1/2010


    05.00.62a, Sculptra® (Injectable Poly-L-Lactic Acid), Radiesse® (Calcium Hydroxylapatite)
    Policy Update
    Posted: 9/1/2010


    06.02.15b, Direct Measurement of Intermediate-Density Lipoproteins
    Notification of Archive
    Posted: 9/1/2010




    Issued on - 10/06/2010